Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer

Details for Australian Patent Application No. 2008308519 (hide)

International Classifications

Event Publications

29 April 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Apr 2010

29 April 2010 Assignment before Grant

ROSKAMP RESEARCH LLC The application has been assigned to Alzheimer's Institute of America, Inc.

29 April 2010 PCT application entered the National Phase

PCT publication WO2009/046323 Priority application(s): WO2009/046323

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.